Design of Auto-Adaptive Drug Delivery System for Effective Delivery of Peptide Drugs to Overcoming Mucus and Epithelial Barriers.
自適應藥物傳遞系統的設計,以有效傳遞肽類藥物以克服黏液和上皮屏障。
AAPS J 2024-09-12
Preparation, Drug Distribution, and In Vivo Evaluation of the Safety of Protein Corona Liposomes for Liraglutide Delivery.
蛋白質環脂體用於利拉魯肽遞送的製備、藥物分佈和體內安全性評估。
Nanomaterials (Basel) 2023-02-14
Folic acid-modified reverse micelle-lipid nanocapsules overcome intestinal barriers and improve the oral delivery of peptides.
葉酸修飾的逆微胞脂質奈米膠囊克服腸道障礙並改善肽的口服給藥。
Drug Deliv 2023-03-04
Fabrication and Evaluation of a pH-Responsive Nanocomposite-Based Colonic Delivery System for Improving the Oral Efficacy of Liraglutide.
製備和評估基於pH敏感納米複合材料的結腸傳遞系統,以提高利拉魯肽口服療效。
Int J Nanomedicine 2023-07-26
Design of chimeric GLP-1A using oligomeric bile acids to utilize transporter-mediated endocytosis for oral delivery.
設計利用寡聚膽酸的嵌合GLP-1A,以利用轉運蛋白介導的內吞作用進行口服給藥。
Biomater Res 2023-11-21
Concept for a Unidirectional Release Mucoadhesive Buccal Tablet for Oral Delivery of Antidiabetic Peptide Drugs Such as Insulin, Glucagon-like Peptide 1 (GLP-1), and their Analogs.
口腔嗅著錠的單向釋放黏附概念,用於口服遞送胰島素、類胰高血糖素1(GLP-1)及其類似物等抗糖尿病肽藥物。
Pharmaceutics 2023-10-03
Systems Biology and Peptide Engineering to Overcome Absorption Barriers for Oral Peptide Delivery: Dosage Form Optimization Case Study Preceding Clinical Translation.
系統生物學和肽工程克服口服肽藥物吸收障礙:劑型優化案例研究在臨床轉化之前。
Pharmaceutics 2023-10-30
Coordinated ASBT and EGFR Mechanisms for Optimized Liraglutide Nanoformulation Absorption in the GI Tract.
ASBT和EGFR協調機制對於在胃腸道中優化Liraglutide納米配方吸收的作用。
Int J Nanomedicine 2024-03-29